Duloxetine Capsule, Delayed Release
Product Images NDC 70518-1054

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 70518-1054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Duloxetine 30mg 70518 1054 01)

This is a bottle of Duloxetine Delayed-Release Capsules with 30mg strength and 90 count. The medication is for prescription use only and expires at a certain date. The manufacturer is Ajanta Pharma Ltd located in India. The bottle also contains the NDC number and Lot number for identification. The medication should be kept out of reach of children and direction on how to use should be followed as indicated on the package insert. The medication should be stored at a recommended temperature range. The bottle was repackaged by RemedyRepack Ine. in Pennsylvania.*

FDA Label Image

Mm3 (Duloxetine 30mg 70518 1054 02)

This is a medication called Duloxetine, which comes in a delayed-release capsule form with a strength of 30 mg. The pack contains 30 capsules and requires a prescription. It was repackaged by a company called RemedyRepack Ine. It has an NDC number and LOT number for tracking purposes. The manufacturer is Ajanta Pharma Ltd, located in India. The instructions on how to use this medication are present in the package insert, and it should be kept out of reach of children. It is advised to store it between 20-25°C (88-77°F) with excursions permitted at 15-30°C (59-86°F) [See USP].*

FDA Label Image

Mm4 (Duloxetine 30mg 70518 1054 03)

This is a description of a medication called DULoxetine, which comes in a 30mg capsule. There are 60 capsules per bottle. The medication is delayed-release and should be stored at a temperature between 20-25°C (88-77°F). This medication requires a prescription and should be kept out of the reach of children. The medication is repackaged by a company called RemedyRepack in Indiana. The directions for use can be found in the package insert. The expiration date and lot number are not available in the given text.*

FDA Label Image

Mm5 (Duloxetine 30mg 70518 1054 04)

This is a description of a medication called DULoxetine in the form of delayed-release capsules that come in 30mg and a quantity of 30. The medication is RX Only and its source NDC is 27241-0098-09 with Lot # not mentioned. It is manufactured by Ajanta Pharma Ltd in Paithan, India. The medication should be kept out of the reach of children, and directions for use can be found in the package insert. It is repackaged by a company called RemedyRepack, Inc based in Indiana, PA 15701. The recommended storage temperature is 20-25°C.*

FDA Label Image

Mm6 (Duloxetine 30mg 70518 1054 05)

This is a description of a medication named DULoxetine. The medication is a capsule with a delayed-release of 30 mg. The package has an NDC number of 70518-1054-05 and an expiration date. It's manufactured by Ajanta Pharma Ltd in Paithan, India. The package insert should be consulted for directions of use. The medication should be stored at 20-25°C (88-77°F) and kept out of reach of children. It was repackaged by RemedyRepack, based in Indiana, PA 15701.*

FDA Label Image

Mm7 (Duloxetine 30mg 70518 1054 06)

This is a medication called DULoxetine, which is in the form of a delayed-release capsule containing 30 mg. The package contains 30 capsules and is manufactured by Ajanta Pharma Ltd in India. The medication is only available with a prescription and should be kept out of the reach of children. The package insert should be followed for directions for use, and the medication should be stored between 20-25°C (88-77°F), with excursions allowed between 15-30°C (59-86°F). The packaging has been done by RemedyRepack Inc. in Indiana.*

FDA Label Image

Duloxetine 30mg 70518 1054 07

Duloxetine is a delayed-release capsule with a strength of 30 mg, packaged in a quantity of 30. It is available only with a prescription and should be kept out of children's reach. The package insert should be consulted for the proper usage of the medication. It can be stored in a temperature range of 20-25°C (88-77°F), with excursions permitted up to 15-30°C (59-86°F) [See USP]. The medication is repackaged by RemedyRepack Ine. in Indiana, PA 15701. The text also includes the lot number, source NDC, and the manufacturer's details.*

FDA Label Image

Duloxetine 30mg 70518 1054 08

DULoxetine is a medication available in the form of 30mg delay-release capsules. It is manufactured by Ajanta Pharma Ltd. in Paithan, India. The product is packaged in a bottle containing 30 capsules, and the recommended storage temperature is between 20-25°C (68-77°F). Additional instructions are available in the package insert. This specific item has been repackaged by RemedyRepack Inc. and a specific lot number and expiration date are required.*

FDA Label Image

Duloxetine 30mg 70518 1054 09

This is a prescription drug called DULoxetine in the form of delayed-release capsules, with a strength of 30mg per capsule. The package contains 90 capsules and requires a prescription from a doctor. The medication is manufactured by Ajanta Pharma Ltd in India and was repackaged by RemedyRepack Inc. in Indiana, USA. The medication should be kept out of the reach of children and stored between 20-25°C. Directions for use are included in the package insert. The expiration date and lot number are not visible.*

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription medication called Duloxetine, which comes in a delayed-release capsule form with a strength of 30mg. The package contains 30 capsules and it is repackaged by RemedyRepack Inc., located in Indiana, PA. The manufacturer of this medication is Ajanta Pharma Ltd, located in Paithan, India. The medication should be stored at a temperature of 20-25°C (68-77°F), and it should be kept out of the reach of children. It is recommended to refer to the package insert for directions on how to use this medication. The expiry date and lot number are not available.*

FDA Label Image

Figure1 (Duloxetine Fig1)

This text appears to be a graph or chart displaying the number of patients with relapse over time from randomization to relapse in days. The chart includes two treatment options - Placebo and DULOXETINE. The numbers 1.0, 084, 064, and 0.4 4 do not seem to provide any context or useful information.*

FDA Label Image

Figure10 (Duloxetine Fig10)

This is a description for a medication called Placebo in conjunction with Duloxetine. It is recommended to take Duloxetine once a day in either a 60mg or 120mg dose. There is a chart showing percent improvement in pain from baseline.*

FDA Label Image

Figure2 (Duloxetine Fig2)

The graph shows the proportion of patients experiencing a relapse after being treated with either placebo or DULOXETINE over a period of 300 days from randomization. The percentage of patients experiencing a relapse decreased significantly with DULOXETINE compared to the placebo group.*

FDA Label Image

Figure3 (Duloxetine Fig3)

This looks like a table with medication names and the corresponding percentage of improvement in pain from baseline for each medication. The medications listed are Duloxetine 60 mg BID, Duloxetine 60 mg QD, Duloxetine 20 mg QD, and a placebo. The text at the bottom left may be a footnote or legend for the chart, but it appears to have been altered or corrupted during , so it is not clear what it says.*

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

This text seems to be a chart or a graph comparing the percentage of patients improved with different dosage of Duloxetine over placebo, in terms of pain relief. It shows that the group of patients treated with Duloxetine 60mg twice daily showed the highest percentage of improvement, followed by those treated with Duloxetine 60mg once daily, and the last group was the placebo one. However, since the text is not well structured and some characters are missing, the information provided is limited and may be difficult to interpret accurately.*

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure8 (Duloxetine Fig8)

This is a description of a medication called Duloxetine, which is taken once daily at a dose of 60 or 120 mg, possibly for pain relief. The document also contains a table displaying the percent improvement in pain from baseline.*

FDA Label Image

Figure9 (Duloxetine Fig9)

This is a clinical study comparing Duloxetine, a drug used to treat depression, and Placebo in reducing pain. However, there isn't enough information to understand the context of the study or its results.*

FDA Label Image

Structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.